Navigation Links
2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
Date:12/13/2007

CLEVELAND, Ohio, December 13 /PRNewswire/ -- Ten new validation studies were published during 2007 on the Simbionix Mentor series of training simulators, bringing the total number of studies published to 65.

"This year we have seen a considerable increase in interest from US and European institutes" said Gary Zamler, Simbionix' CEO. "Some of the world's most highly respected academic medical institutions and teaching hospitals have completed studies measuring the efficacy of using Simbionix Mentor simulation products."

The studies published this year include two new studies on the GI Mentor, two on the URO/PERC platform, three on the LAP Mentor and three on the ANGIO Mentor. Some of the studies were carried out at multiple sites, something that typically increases the reliability of study results. The institutes which conducted studies include the University of Texas, Catharina Hospital of the Netherlands, the British Imperial College of London and the Graduate School of Medical Sciences in the Kyushu University of Fukuoka, the first study by a Japanese institute to date.

The study carried out by experts at Catharina Hospital's Department of Gastroenterology concluded that the GI Mentor II simulator offered a convincing, realistic representation of colonoscopy that can discriminate between different levels of colonoscopy expertise. As a result, the product was granted both construct validity and expert validity. The study carried out by Kyushu University of Fukuoka concluded that the LAP Mentor was able to differentiate between subjects with different laparoscopic experience.

One of the key value points for medical institutions to use Simbionix products is the ability to offer clinicians and medical students the required hands-on surgical experience at zero patient risk. Validation studies are critical to prove the efficacy of the simulation experience, so that institutions can rely on simulators to advance clinician training and i
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
2. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
3. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
4. Life on Mars pregnancy test successfully launched
5. Of mice and men: new male contraceptives successful in rodents and humans
6. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
7. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
8. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
9. James Webb Space Telescope marks successful completion
10. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Contec’s Sporicidin disinfectant solut...grade disinfectants against H1N1 and Influenza A.,...) November 24, 2009 -- Contec Inc, the leading man...that their Sporicidin disinfectants have been de... A viruses, including Pandemic 2009 H1N1 influenza...
(Date:11/23/2009)...ov.23/PRNewswire/-InimexPharmaceuticals,Inc.announ...sPresidentandCEO. ,, Abramsbringsmorethan25year...eisaco-inventorofthenuclearmedicineimagingagent,Ca...lcwherehewasManager,BiomedicalResearchWorldwide.In...CandwasPresidentandCEOfrom1996to2006.AnorMEDdiscov...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...eguard Mezzanine Debt Facility; Support Profitable...nt , Inc. (Nasdaq: CLRT ), a premier anatomic p...or pathologists, oncologists and the pharmaceutica...the second tranche of a private placement of conve...ers , a multi-stage venture capital firm based in...
...a-FirstCall/ -- China Dasheng,Biotechnology Compan... Board:,CDBT), a leading producer and distributor ...livestock feeds in the PRC, announced unaudited fi...ar 2009, which ended March 31, 2009. , , Highli... -- Total revenue grew approximately 43% to $5....
...ia-FirstCall/ -- Rodobo International,Inc. (OTC Bu...t dairy,companies in China, reported financial res...nded March 31, 2009. , Second quarter financia... quarter ended March 31, 2009 was $6.3 million, an...e was primarily driven by,volume growth, with aver...
Other Biology Technology:Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 2Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 3Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 4Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 5Clarient Completes Second Tranche of Private Placement of Convertible Preferred Stock With Oak Investment Partners 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 2China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 3China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 4China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 5China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 6China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 7China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results 8Rodobo International, Inc. Reports Q2 and First Half of 2009 2Rodobo International, Inc. Reports Q2 and First Half of 2009 3Rodobo International, Inc. Reports Q2 and First Half of 2009 4Rodobo International, Inc. Reports Q2 and First Half of 2009 5Rodobo International, Inc. Reports Q2 and First Half of 2009 6Rodobo International, Inc. Reports Q2 and First Half of 2009 7Rodobo International, Inc. Reports Q2 and First Half of 2009 8
(Date:11/23/2009)...g of recent discoveries about the multiple health ... multi-purpose nutrient, increased awareness of th...spurred research and even led to an appreciation o...ng from the health of your immune system to preven...fluenza, vitamin D is now seen as one of the most ...
(Date:11/23/2009)...sify the gender of six-week-old turkey poults coul...hortly after birth, according to Dr. Gerald Steine...many and his team. Their use of infrared spectrosc...hat it is a fast and accurate method with the pote...ify and select female eggs for breeding. The pilot...
(Date:11/23/2009)...le in German . , A bit of imagination on th... thing. It could help to add data from areas where...must do so constructively. In order to infer missi...han just imagination, physicists at the Max Planck...ry of spatial perception called information field ...
Breaking Biology News(10 mins):Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Rescuing male turkey chicks 2Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Delcath Systems Inc Prices 2430 6 Million Stock Offering 6237 1Delcath Systems Inc Prices 2430 6 Million Stock Offering 6237 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 13SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 23SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 33SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 43SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 53SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 63SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 73SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 83SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 93SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 103SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 113SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 123SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 133SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 143SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 153SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 163SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 173SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 183SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 193SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 203SBio Inc Announces Unaudited Third Quarter 2009 Results 14823 21Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 1Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 2Compirion Healthcare Solutions Wins Consulting Contracts With Three Hospitals 61274 3
...ate University have made a major discovery on the ...anisms of one of life,s most elemental functions: ... for how a normal cell forms a tumor and how a vir...13 edition of the scientific journal Molecular Cel...ds exquisite nanotechnology in living systems and ...
...d be saved if $5.1 billion in new resources for pr...ed each year, according to researchers from the Jo...other institutions. Approximately 90 percent of al...rld. In those countries, the average cost per chil...e recent publication of the potential impact of pr...
...rthern and southern hemispheres are linked by a ph...ither side of the planet. A research team from the... University has shown for the first time that ocea...he past, adapted to sudden changes in the north. T... more accurate forecasts to be made on how the oce...
Other Biology News:High fidelity keeps human DNA assembly line humming 2$5.1 billion would save 6 million children 2$5.1 billion would save 6 million children 3Climatologists discover deep-sea secret 2
Finnpipette Focus Single Channel Long Tip Cone 30-300l from Thermo Scientific
Hae III (High Concentration) from Takara Mirus Bio
BamH I from New England Biolabs
...ectrophoresis (2D-PAGE) with biological mass spect...atform for proteomic analysis. 2D-PAGE gels offer ...imited only in the dynamic range and ability to re... based analysis of separated proteins has been a m...
Biology Products: